London
· Delayed Price · Currency is GBP · Price in GBXAllergy Therapeutics Company Description
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments.
The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Acarovac Plus, Pollinex, Synbiotics, and VLP Peanut.
The company develops allergy vaccines for pollen, house dust mites, and animal fur, as well as peanut allergy vaccines.
It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
| Country | United Kingdom |
| Founded | 2004 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 612 |
| CEO | Manuel Llobet |
Contact Details
Address: Dominion Way Worthing, BN14 8SA United Kingdom | |
| Phone | 44 1903 844 700 |
| Website | allergytherapeutics.com |
Stock Details
| Ticker Symbol | AGY |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | July - June |
| Reporting Currency | GBP |
| ISIN Number | GB00B02LCQ05 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Manuel Llobet | Chief Executive Officer |
| Shaun Furlong | Chief Financial Officer |
| Beverly Lees | Chief Operating Officer |